Gene · 6121
Papers3,325
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,325
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of Lung Adenocarcinoma Subtypes Using Growth Hormone-Releasing Hormone-Related Genes and Establishment of Signature to Predict Prognosis and Guide Immunotherapy. | J Environ Pathol Toxicol Oncol | 2025 | 40493898 | PubTator, text mining | PubMed |
| Metabolic profiles in laryngeal cancer defined two distinct molecular subtypes with divergent prognoses. | Front Immunol | 2025 | 40475768 | PubTator, text mining | PubMed |
| Identification of different lung adenocarcinoma subtypes in combination with antidiuretic hormone-related genes and creation of an associated index to predict prognosis and guide immunotherapy. | Comput Biol Chem | 2025 | 40412340 | PubTator, text mining | PubMed |
| Defining lung adenocarcinoma subtypes with glucocorticoid-related genes and constructing a prognostic index for immunotherapy guidance. | J Thorac Dis | 2025 | 40400930 | PubTator, text mining | PubMed |
| RPE65 variant p.(E519K) causes a novel dominant adult-onset maculopathy in 83 affected individuals. | Res Sq | 2025 | 40386434 | PubTator, text mining | PubMed |
| Genetics and phenotypes of RPE65 mutations in inherited retinal degeneration: A study from a tertiary eye care center in Brazil. | Mol Vis | 2025 | 40384766 | PubTator, text mining | PubMed |
| Effect of methotrexate/dexamethasone combination on epithelial-mesenchymal transition and inflammation gene expression of human RPE cells in-vitro. | Front Pharmacol | 2025 | 40371355 | PubTator, text mining | PubMed |
Correction: Letter to the editor relating to Stingl K, Priglinger C, Herrmann P. "RPE65-Associated Retinal Dystrophies: Phenotypes and Treatment Effects with Voretigene Neparvovec" Klin Monbl Augenheilkd 2024; 241(03): 259-265. DOI: 10.1055/a-2227-3671. | Klin Monbl Augenheilkd | 2025 | 40334704 | PubTator, text mining | PubMed |
| AZGP1 Attenuates Subretinal Fibrosis and Inhibits Epithelial-Mesenchymal Transition by Blocking the PI3K/AKT Signaling Pathway. | Invest Ophthalmol Vis Sci | 2025 | 40305469 | PubTator, text mining | PubMed |
| Advances and therapeutic opportunities in visual cycle modulation. | Prog Retin Eye Res | 2025 | 40280538 | PubTator, text mining | PubMed |
| Retina-directed gene therapy: Achievements and remaining challenges. | Pharmacol Ther | 2025 | 40268248 | PubTator, text mining | PubMed |
| Corrigendum to: Long-term experience with gene augmentation therapy in patients with inherited retinal disease associated with biallelic mutations in RPE65. | Med Genet | 2025 | 40207040 | PubTator, text mining | PubMed |
| Improvements induced by retinal gene therapy with voretigene neparvovec depend on visual cortical hemispheric dominance mechanisms. | Commun Med (Lond) | 2025 | 40204976 | PubTator, text mining | PubMed |
| Response to Letter Regarding Our Paper on RPE65-Associated Retinal Dystrophies. | Klin Monbl Augenheilkd | 2025 | 40174897 | PubTator, text mining | PubMed |
| Effects of exosomes derived from activated corneal stromal keratocytes on the inflammation, proliferation, neuroprotection and epithelial-mesenchymal transition in retinal pigment epithelium cells. | Life Sci | 2025 | 40174671 | PubTator, text mining | PubMed |
| Validation of a quantitative cell-based relative potency assay for LUXTURNA. | Mol Ther Methods Clin Dev | 2025 | 40104153 | PubTator, text mining | PubMed |
| Voretigene neparvovec in RPE65-related inherited retinal dystrophy: the 1-year real-world study LIGHT. | Eye (Lond) | 2025 | 40087508 | PubTator, text mining | PubMed |
| Genetic mutation in HSF4 is associated with retinal degeneration in mice. | Exp Eye Res | 2025 | 40023307 | PubTator, text mining | PubMed |
| A Comprehensive Review of Clinically Applied Adeno-Associated Virus-Based Gene Therapies for Ocular Disease. | Hum Gene Ther | 2025 | 39989340 | PubTator, text mining | PubMed |
| Relatively preserved retinal function in RPE65-associated retinopathy: a case report. | Doc Ophthalmol | 2025 | 39976817 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6121/papers?page=6